The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

Angela Huttner, Claire‐Anne Siegrist, Sabine Yerly et al.|The Lancet Infectious Diseases|2015

Cited by 278